138 related articles for article (PubMed ID: 23473757)
21. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M
Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317
[TBL] [Abstract][Full Text] [Related]
22. Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.
Ray AM; Zuhlke KA; Johnson GR; Levin AM; Douglas JA; Lange EM; Cooney KA
Br J Cancer; 2009 Dec; 101(12):2043-7. PubMed ID: 19935797
[TBL] [Abstract][Full Text] [Related]
23. Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract][Full Text] [Related]
24. ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women.
Yang YC; Chang TY; Chen TC; Lin WS; Chang SC; Lee YJ
Oncotarget; 2017 Feb; 8(6):10085-10090. PubMed ID: 28036301
[TBL] [Abstract][Full Text] [Related]
25. Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study.
Flaum N; van Veen EM; Smith O; Amico S; Newman WG; Crosbie EJ; Edmondson R; Smith MJ; Evans DG
Clin Genet; 2022 Jan; 101(1):48-54. PubMed ID: 34585738
[TBL] [Abstract][Full Text] [Related]
26. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
[TBL] [Abstract][Full Text] [Related]
27. Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.
Martínez-Nava GA; Fernández-Niño JA; Madrid-Marina V; Torres-Poveda K
PLoS One; 2016; 11(7):e0157344. PubMed ID: 27415837
[TBL] [Abstract][Full Text] [Related]
28. Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis.
Pabalan N; Jarjanazi H; Ozcelik H
Breast Cancer Res Treat; 2013 Jan; 137(2):553-8. PubMed ID: 23225146
[TBL] [Abstract][Full Text] [Related]
29. [Variations within OLF1/EBF-associated zinc finger protein gene confer susceptibility to lupus nephritis in Chinese population].
Liang D; Huang XQ; Shen N; Mao HQ; Feng XB; Huang XF; Tang JP; Chen XX; Chen SL; Gu YY; Bao CD; Wang Y; Qian J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):949-54. PubMed ID: 16061000
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants in BRIP1 (BACH1) contribute to risk of nonsyndromic cleft lip with or without cleft palate.
Mostowska A; Hozyasz KK; Wójcicki P; Galas-Filipowicz D; Lasota A; Dunin-Wilczyńska I; Lianeri M; Jagodziński PP
Birth Defects Res A Clin Mol Teratol; 2014 Sep; 100(9):670-8. PubMed ID: 25045080
[TBL] [Abstract][Full Text] [Related]
31. BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study.
Frank B; Hemminki K; Meindl A; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
BMC Cancer; 2007 May; 7():83. PubMed ID: 17504528
[TBL] [Abstract][Full Text] [Related]
32. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.
Suszynska M; Ratajska M; Kozlowski P
J Ovarian Res; 2020 May; 13(1):50. PubMed ID: 32359370
[TBL] [Abstract][Full Text] [Related]
33. Association of p21 SNPs and risk of cervical cancer among Chinese women.
Wang N; Wang S; Zhang Q; Lu Y; Wei H; Li W; Zhang S; Yin D; Ou Y
BMC Cancer; 2012 Dec; 12():589. PubMed ID: 23231583
[TBL] [Abstract][Full Text] [Related]
34. Whole exome sequencing of breast cancer (TNBC) cases from India: association of MSH6 and BRIP1 variants with TNBC risk and oxidative DNA damage.
Aravind Kumar M; Naushad SM; Narasimgu N; Nagaraju Naik S; Kadali S; Shanker U; Lakshmi Narasu M
Mol Biol Rep; 2018 Oct; 45(5):1413-1419. PubMed ID: 30136158
[TBL] [Abstract][Full Text] [Related]
35. The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.
Hu M; Zheng J; Zhang L; Jiang L; You Y; Jiang M; Li H
DNA Cell Biol; 2012 Jul; 31(7):1167-73. PubMed ID: 22335172
[TBL] [Abstract][Full Text] [Related]
36. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families.
Solyom S; Pylkäs K; Winqvist R
Fam Cancer; 2010 Dec; 9(4):537-40. PubMed ID: 20567916
[TBL] [Abstract][Full Text] [Related]
37. Association between IL1B gene and cervical cancer susceptibility in Chinese Uygur Population: A Case-Control study.
Wang L; Zhao W; Hong J; Niu F; Li J; Zhang S; Jin T
Mol Genet Genomic Med; 2019 Aug; 7(8):e779. PubMed ID: 31222982
[TBL] [Abstract][Full Text] [Related]
38. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
39. Association between the ELAVL1 gene single nucleotide polymorphisms and the Genetic Susceptibility to cervical cancer by high resolution melting in a Tunisian population.
Boudhiba N; Sfar S; Helaoui A; Bouanene I; Hołysz M; Skalska E; Bouchahda H; Jagodziński PP; Kenani A
Mol Biol Rep; 2023 Mar; 50(3):2559-2567. PubMed ID: 36626067
[TBL] [Abstract][Full Text] [Related]
40. BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.
Ouhtit A; Gupta I; Shaikh Z
Front Biosci (Elite Ed); 2016 Jan; 8(2):289-98. PubMed ID: 26709662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
